Capital Advisory Group Advisory Services, LLC Dexcom Inc Transaction History

Capital Advisory Group Advisory Services, LLC

$276 Million
Q4 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$67.99 - $132.89 $37,462 - $73,222	-551 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$94.08 - $130.2 $1,599 - $2,213	-17 Reduced 2.99%	551 $282,000
Q4 2021 Feb 15, 2022	BUY	$129.87 - $162.82 $259 - $325	2 Added 0.35%	568 $305,000
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $106 - $143	-1 Reduced 0.18%	566 $310,000
Q2 2021 Nov 12, 2021	SELL	$80.99 - $107.93 $3,158 - $4,209	-39 Reduced 6.44%	567 $242,000
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $1,695 - $2,094	20 Added 3.41%	606 $218,000
Q4 2020 Feb 18, 2021	BUY	$78.0 - $104.5 $44,928 - $60,192	576 Added 5760.0%	586 $217,000
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $955 - $1,129	10 New	10 $4,000

Others Institutions Holding DXCM

# of Institutions

1,024

Shares Held

352M

Call Options Held

5.51M

Put Options Held

5.61M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Account